IPO Plus

₹0.82

▲ +0.03 +3.80%

As of 28 Oct 2026 · delayed

BSE Listed

GSM · GSM 0
What does GSM · GSM 0 mean?
BSE · Graded Surveillance Measure (GSM 0)GSM targets fundamentally weak companies whose price doesn't square with their financials (tiny net worth or negative/extreme P/E). Practical meaning: the exchange doubts the price is backed by the business. Stage 0 is a watchlist; each higher stage makes the stock progressively harder to trade — tighter bands, full upfront margin, weekly-only trading, and at Stage IV no upward price movement at all. Exiting requires a quarterly review finding the criteria no longer met.Criteria: Shortlisted on objective financial parameters — net worth, net fixed assets, price-to-earnings multiple and market capitalisation. Stage 0 = base surveillance watchlist (identified under GSM, no graded price restriction yet); Stages I–VI add escalating curbs (price band, 100% margin, periodic call auction, settlement on a gross/trade-for-trade basis, no upward price movement).

Amerise Biosciences Limited (531681)

Volume: 27,690Avg Vol 1W: 44,022Avg Vol 1M: 27,29852W Range:₹0.5₹1.03
Key Ratios
Checked 8h ago
Market Cap₹5 Cr
Current Price₹0.82
Previous Close₹0.79
High / Low (52w)₹1.03 / ₹0.5
Volume27,690
Avg Vol (1W)44,022
Avg Vol (1M)27,298
Stock P/E—
Book Value₹0.82
Dividend Yield0%
ROE29.84%
ROA-67.39%
Revenue (TTM)—
Revenue Growth—
Profit Margin0%
Total Debt—
Shares Outstanding7 Cr
Face Value—
EPS (TTM)₹0
P/B1
Debt / Equity0
50 DMA₹0.82
200 DMA₹0.76
Day change+3.80%
SurveillanceGSM · GSM 0
Price Chart
₹0.82▲ 24.24% · 1Y
₹1₹17.9L
2025-10-28
2026-10-28

20-day avg volume: 29K shares

Pros
  • Healthy return on equity of 29.8%.
  • Company is almost debt-free.
  • Revenue grew 36% YoY.
  • Net profit is growing year over year.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹1 Cr₹0 Cr₹0 Cr₹10 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EPS0-0.02-0.050.08-0.02-0.0200
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹6 Cr₹6 Cr₹6 Cr₹12 Cr₹6 Cr₹5 Cr₹8 Cr₹7 Cr
Total Liabilities₹0 Cr₹1 Cr₹1 Cr₹6 Cr₹0 Cr₹0 Cr₹3 Cr₹2 Cr
Equity₹6 Cr₹5 Cr₹5 Cr₹6 Cr₹6 Cr₹5 Cr₹5 Cr₹5 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹3 Cr₹-1 Cr
Investing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-3 Cr₹2 Cr
Financing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Free Cash Flow₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹3 Cr₹-1 Cr
Shareholding
Promoter 0% Institutions 0% Public 100%
Efficiency & Working Capital
ROCE0.4%
Interest Coverage0
Dividend Payout—
Debtor Days—
Inventory Days—
Payable Days—
Cash Conversion Cycle—
Working Capital Days—
Shareholding Details

As of 2026-09-30

Promoter0%
FII0%
DII0%
Institutions0%
Public100%
Promoter Pledge—
No. of Shareholders33,026
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Promoters0%0%0%0%0%0%0%0%0%0%0%0%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public100%100%100%100%100%100%100%100%100%100%100%100%
Promoter Pledge————————————
No. of Shareholders20,83123,48523,32327,07735,14236,59536,21735,67635,18034,51933,84833,026
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Snehjeev Ventures Private LimitedPublic Shareholding4.8%31,73,345
Amrapali Industries LimitedPublic Shareholding4.4%29,09,206
Jagkarta Agencies Private LimitedPublic Shareholding4.1%27,18,000
Dristi Fashions Private LimitedPublic Shareholding4.1%27,00,000
Twist Barter Private LimitedPublic Shareholding4.1%27,05,515
Sneha Sanjeev LunkadPublic Shareholding4%26,16,738
Kamna Coal Private LimitedPublic Shareholding3.1%20,31,631
Riddhi LunkadPublic Shareholding3%19,80,547
Amrapali Fincap LimitedPublic Shareholding2.8%18,63,902
Compact Fashions Private LimitedPublic Shareholding1.9%12,73,376
Destiny Procon Private LimitedPublic Shareholding1.9%12,19,000
Board of Directors
NameDesignationYear
Dineshkumar Tribhovanbhai RathodWhole Time Director & CFO2025
Kelash BunkarIndependent Non Exe. Director2025
Manisha Maneklal PatelIndependent Non Exe. Director2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹1877
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-03Board Meetings—
Substantial Acquisitions (SAST)

7 disclosure(s)

Market14/08/2026 · 76,725
Market20/07/2026 · 28,000
Market15/07/2026 · 3,18,285
Market15/07/2026 · 3,18,285
Market06/07/2026 · 38,574
Margin04/06/2026 · 32,000
Company Information
Incorporated1984
AuditorBipin & Co
Investor Email[email protected]
🌐 www.amerisebiosciencesltd.shop ↗

📍 PO5-02D 5th Floor Tower A WTC, Gift City, Gandhinagar, Gujarat, 382355

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search

Telegram App